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New Ni(II), Cd(II) and Hg(II) complexes of a pyrazole based Schiff base ligand, MPzOATA, 
have  been synthesized and physico-chemically & spectroscopically characterized. The structural 
conformations of the reported complex species have been established by single crystal X-ray 
studies. The emission properties and the antimicrobial activities of the metal ion materials have 
been reported. 
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 Abstract 
Herein, we report the syntheses and structures of Ni(II) complexes, [Ni(MPzOATA)2] (Cl) (PF6) 
(I), [Ni(MPzOATA)2](ClO4)2.CH3CN (II) & [Ni(MPzOATA)2](BF4)2.H2O (III); Cd(II) complex, 
[Cd(MPzOATA)Cl2]2  (IV) and a Hg(II) complex, [Hg(MPzOATA)Cl2]  (V), of a pyrazole based 
‘NNS’ donor ligand, 5-methylpyrazole-3yl-N-(2´-methylthiophenyl)methyleneimine, 
(MPzOATA). The complexes are characterized by elemental analyses, electronic, IR, 1H-NMR 
(only for IV & V) spectral parameters, conductivity and fluorescence measurements.  X-ray 
crystallographic data of the complexes reveal that the Ni(II) complexes have NiN4S2 octahedral 
coordination, one of them is a mixed-anion complex having Cl- and PF6-  as counter anions; the 
Cd(II) complex is a chloro bridged binuclear complex with octahedral coordination environment 
around each metal centre, while the Hg(II) complex is a square pyramidal one. Among the 
reported complex species, the Ni(II) complexes are non-fluorescent, while the Cd(II) and Hg(II) 
complexes can be used as potential photoactive materials as indicated from their characteristic 
emission properties. The reported complexes are screened for their antimicrobial activities 
against some Gram positive and Gram negative microbial strains, and they are found to be 
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potential antimicrobial agents in broad spectrum against both Gram positive and Gram negative 
bacteria.   
 
Keywords:   Pyrazole, Schiff-base, Cd(II), Hg(II), X-ray Crystallography, Antibacterial potential, 
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1. Introduction 
Coordination chemistry of transition metal ions with various Schiff base ligands have been the 
area of interest in recent years because of wide range of geometry leading to structural diversity 
and application in various fields like biological, medicinal, analytical and as catalyst in organic 
reactions [1-16].  Schiff base ligands having Nitrogen-Sulfur as coordination sites towards metal 
ions, are important building blocks for metal-organic moieties. The chelating nitrogen and sulfur 
atoms can stabilize unusual oxidation states and uncommon coordination numbers in metal ion 
complexes [17]. During the last few years a significant attention has been given in using of 
heterocyclic compounds having nitrogen as donor site(s) for ligation with various transition 
metal ions; the π-electrons present on the hetero-atom(s) actively take part in the formation of 
stable metal-ligand (M-L) bonds during complex formation. Pyrazole (1:2 diazole), a five-
membered nitrogen containing heterocycle, being isomeric with imidazole (1:3 diazole), an 
essential part of the well-known histidine residue of many proteins, has drawn substantial 
attention of chemists as a coordinating ligand for complexation since the reporting of [Ag(pz)]n 
in 1889 [18]; subsequently a large number of coordination complexes of pyrazole containing 
ligands with various biologically relevant transition metal ions like Fe(III), Co(III), Ni(II), Cu(II) 
etc. have been reported [19]. The application of coordination complexes with pyrazole 
containing ligands as biological models is well-documented [20]. Among the transition metal ion 
complexes, investigation of nickel compounds is of great interest in chemistry for their         
renowned bioactivity and catalytic activity in many organic reactions [21-24]. On the other hand 
d10 metal ions are well recognized for their catalytic activity, emissive property and application 
as opto-electronic materials, and uses in environmental chemistry [25-28]. The coordination 
chemistry of cadmium and mercury is the point of interest, because of the facts that the ions are 
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capable of affording a number of coordination numbers and geometries owing to their d10 
configuration; their toxic environmental effects, mobilization and immobilization in the 
environment, in living organisms, and in certain chemical processes like ligand exchange 
chromatography depend remarkably on their complexation with ligands having nitrogen as donor 
site(s) [29]. With this background and in continuation of our previous work [30], this 
communication is intended to report the syntheses and  characterizations of Ni( I), Cd(II) and 
Hg(II) complexes of  a ‘NNS’ tridentate ligand, 5-methylpyrazole-3yl-N-(2´-methylthiophenyl)-
methyleneimine (MPzOATA) (Figure 1) together with the fluorescence emission of the Cd(II) 
and Hg(II) complexes at room temperature. The antimicrobial properties of the synthesized 
complexes are analyzed in vitro against some Gram positive and Gram negative bacterial strains. 
 
2. Experimental 
 2.1. Materials and physical measurements 
All the solvents and reagents were of AR/GR grade and obtained from commercial sources and 
used without further purification. Spectral and conductance measurements were performed using 
spectrograde solvents. Elemental analyses (C, H and N) were done with a Perkin-Elmer 2400 
CHNS/O analyzer. The molar conductance values of the complexes in methanol (CAS NO. 67-
56-1) were measured with a Systronics 306 digital conductivity meter. The electronic spectra and 
the diffuse reflectance spectra were recorded on a Shimadzu UV-2401PC spectrophotometer. IR 
spectra (4000-450 cm-1) were recorded on a Perkin Elmer L120-000A FT-IR spectrophotometer 
with KBr pellets (CAS No. 7758-02-3). 1H NMR spectra for the complexes were recorded in d6-
DMSO (CAS No. 2206-27-1) with a Bruker AC 400 NMR spectrometer. The fluorescence 
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spectra of the complexes in methanol were recorded using a Perkin-Elmer LS 55 Fluorescence 
Spectrometer. 
2.2. Syntheses 
2.2.1. Synthesis of ligand, MPzOATA 
The title ligand, MPzOATA, had been synthesized and thoroughly characterized by various 
physico-chemical & spectral parameters, as reported in an earlier communication [30a]. 
 
2.2.2. Syntheses of complexes, [Ni(MPzOATA)2] (Cl) (PF6) (I), [Ni(MPzOATA)2](ClO4)2. CH3CN 
(II), [Ni(MPzOATA)2] (BF4)2.H2O (III), [Cd(MPzOATA)Cl2]2 (IV) and [Hg(MPzOATA)Cl2] (V) 
The complex I was synthesized by refluxing together methanol solutions of the primary ligand, 
MPzOATA (0.00105 mol) and NiCl2.6H2O (CAS No. 7791-20-0) (0.000525 mol) on water bath 
for ~1 hour; then 0.00105 mole solid KPF6 (CAS No. 17084-13-8) was added slowly with 
stirring for an hour. On slow evaporation of the resulting solution, dark brown  shiny crystalline 
solid separated out, was filtered off, washed with cold methanol and finally dried over anhydrous 
CaCl2 (yield~75%). Diffractable quality single crystals of [Ni(MPzOATA)2] (Cl) (PF6) were 
obtained on slow evaporation of the methanol solution of the complex. Similarly, complexes II 
and III were synthesized by refluxing mixture of methanol solutions of the ligand (0.00105 mol) 
and Ni(ClO4)2.6H2O (CAS No. 13520-61-1) / Ni(BF4)2.6H2O (CAS No. 13877-16-2) (0.000525 
mol), on water bath for ~1 hour. On slow evaporation of the resulting reaction mixtures, each of 
the desired Ni(II) complex separated out as brown crystalline solid, was filtered off, washed with 
cold methanol and was dried over anhydrous CaCl2 (yield ~75-80%). X-ray quality single 
crystals of II and III were obtained on slow crystallization of the acetonitrile (CAS No. 75-05-8) 
and methanol solution of the respective complexes. The complexes IV and V had been 
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synthesized by refluxing together equimolar (0.00105 mol) mixture of the primary ligand and 
CdCl2.2H2O (CAS No. 72589-96-9) / HgCl2 (CAS No. 7487-94-7) in ethanol, on water bath for 
~1 hour. The desired complex, in each case, separated out as colorless crystalline solids upon 
slow evaporation of the resulting reaction mixture, was filtered off, washed with cold ethanol and 
was allowed to dry over anhydrous CaCl2 (yield ~70-80%). Single crystals of 
[Cd(MPzOATA)Cl2]2 and [Hg(MPzOATA)Cl2] obtained on slow evaporation of the reaction 
mixtures of the complex species were found suitable for X-ray diffraction. 
Anal. Calcd.(%) for C24H26ClF6N6PS2Ni  (I): C, 41.0; H, 3.7; N, 11.9; Ni, 8.4. Found (%): C, 
40.8; H, 3.5; N, 12.1; Ni, 8.3.  Anal. Calcd. (%) for
 
C26H29Cl2N7O8S2Ni (II):  C, 40.9; H, 3.8; N, 
12.9; Ni, 7.7. Found (%): C, 40.6; H, 3.5; N, 13.0; Ni, 7.4. Anal. Calcd. (%) for
  
C24H28B2N6F8OS2Ni (III):  C, 40.4; H, 3.9; N, 11.8; Ni, 8.2. Found (%): C, 40.3; H, 3.7; N, 12.0; 
Ni, 8.1.  Anal. Calcd. (%) for
 
C24H26Cd2Cl4N6S2 (IV):   C, 34.7; H, 3.2; N, 10.1; Cd, 27.1. Found 
(%): C, 34.3; H, 3.0; N, 10.3; Cd, 26.8.   Anal. Calcd. (%) for
 
C12H13N3Cl2SHg (V): C, 28.6; H, 
2.6; N, 8.4; Hg, 4.0. Found(%): C, 28.3; H, 2.6; N, 8.5; Hg, 3.7. 
 
 
2.3. Structure determination 
X-ray diffraction data of the complex species were collected either at 173 K (I) using a Rigaku 
FR-X Ultrahigh Brilliance Microfocus RA generator/confocal optics and XtaLAB P200 system 
(Mo Kα radiation, λ = 0.71073 Å), at 295 K (II) by using an Agilent Xcalibur Gemini 
diffractometer with graphite monochromator and Ruby CCD system (Cu Kα radiation, λ = 
1.54178 Å), at 93 K (III) by using a Rigaku MM007 High Brilliance RA generator/confocal 
optics and Mercury 70 CCD system (Mo Kα radiation, λ = 0.71073 Å), or at 123 K (IV and V) 
by using an Agilent Xcalibur Gemini diffractometer with graphite monochromator and Ruby 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
CCD system (Mo Kα radiation, λ = 0.71073 Å). Intensity data were collected using ω steps (I, 
II, IV and V) or both ω and φ steps (III) accumulating area detector images spanning at least a 
hemisphere of reciprocal space, and were  corrected for Lorentz polarization and absorption 
effects. Multiscan absorption corrections were applied using Crystal Clear [31] (I and III) or the 
SCALE3 ABSPACK scaling algorithm implemented in CrysAlisPro v1.171.35.11 [32] (V), and 
analytical absorption corrections were applied using a multifaceted crystal model [33] 
implemented in CrysAlisPro v1.171.35.11 [32] (II and IV). The structures were solved by direct 
(SIR2004 [34], SHELXS-97 [35]) or Patterson methods (DIRDIF99 PATTY [36]) and refined 
using full-matrix least squares (SHELXL-2013 [37] and SHELXL-97 [35]). All aliphatic and 
aromatic hydrogen atoms were assigned riding isotropic displacement parameters and 
constrained to idealized geometries. Hydrogen atoms bound to N or O in I or III were located 
from the difference Fourier map and refined subject to a distance restraint, while those in the 
other structures were assigned riding isotropic displacement parameters and constrained to 
idealized geometries. The crystallographic data are summarized in Table 1. 
 
2.4. Antimicrobial Activity 
 
In vitro antimicrobial analyses were performed to evaluate the antimicrobial potential of those 
synthesized compounds under study against six selected bacterial strains namely Salmonella 
enterica ser. typhi SRC, Proteus vulgaris OX19, Bacillus subtilis 6633, Enterobacter aerogenes 
10102, Staphylococcus aureus and Escherichia coli K12. Those microbial strains comprising of 
two Gram positive and four Gram negative ones, were obtained from Microbial Type Culture 
Collection and Gene Bank (MTCC), Institute of Microbial Technology, Chandigarh and 
Department of Microbiology, University of Kalyani. Amoxicillin (CAS No. 61336-70-7), a 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
clinically recommended antibacterial agent was used as the reference antimicrobial agent [30a]. 
The compounds were dissolved in dimethyl sulfoxide (DMSO) (CAS No. 67-68-5) and final 
concentration of DMSO was maintained constant (up to 1%). Nutrient Broth /Agar (Modified) 
was used for in vitro antimicrobial analysis and minimum inhibitory concentrations (MIC) of 
these compounds were determined as per NCCLS protocol [38]. Bacterial susceptibility of these 
compounds was assessed using agar well diffusion method [39]. Subjected to those compounds 
the microbial growth kinetics was evaluated with two bacterial strains (Bacillus subtilis 6633 and 
Enterobacter aerogenes 10102). 
Bacterial membrane damage assay was also performed to further verify the efficacy of the 
complexes on bacterial cell membrane integrity. Membrane damage was determined by 
quantifying the quantum of nucleic acids released from the cell interior [40, 41]. This assay was 
performed on a gram positive (Bacillus subtilis 6633) and a gram negative (Proteus vulgaris 
OX19) bacterial strain as representative from two distinct groups under study. Overnight culture 
of both the bacterial strains was centrifuged at 7000 rpm for 5 min. The cell pellet was washed 
thrice with phosphate buffer saline (PBS, pH 7.4) and resuspended in the specific liquid culture 
media. The optical density of the bacterial suspension was set 0.8 at 420 nm and distributed into 
different conical flasks. The concentration of the complexes was set at the specific MIC of the 
individual complexes determined beforehand against the bacterial strains. A control set was 
prepared without addition of the complexes. In every one hour two mL of sample was collected 
and filtered with 0.2 µm syringe filter and the filtrate was measured at 260 nm in a UV-Vis 
spectrophotometer to estimate the amount of nucleic acids released in the mean time. 
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3. Results and discussion 
The title ligand, MPZOATA, was characterized by elemental analyses (C, H and N), IR, 1H-
NMR and mass spectrum studies and the results had been reported earlier [30a].  
3.1. Characterization of the complexes 
The reported complexes gave satisfactory C, H, N and metal analyses and conformed to the 
composition as [Ni(MPzOATA)2](PF6,Cl) I, [Ni(MPzOATA)2](ClO4)2.CH3CN II, 
[Ni(MPzOATA)2](BF4)2.H2O III, [Cd(MPzOATA)Cl2]2 IV and [Hg(MPzOATA)Cl2] V. The 
molar conductance values in MeOH (30°C) classified I, II and III as 1:2 electrolytes (λM = 230, 
280 and 229 ohm–1cm2mol–1 for I, II and III, respectively); IV and V as non-electrolytes (λM= 45 
and 58 ohm–1cm2mol–1, respectively) [42].  
The characteristic IR bands (4000-450 cm-1) provided meaningful information regarding the 
binding sites of the primary ligand molecules with the central metal ions. IR bands appeared in 
the region (1595-1608 cm-1) in the complex species are consistent with the coordination of the 
azomethine nitrogen (CH=N) to the central metal ion, whereas bands obtained at 469-473 cm-1 
are then assignable to ν(M-N azomethine). IR bands found at 1568-1578 cm-1 are indicative of 
participation of the tertiary ring nitrogen atom (2N) as potential binding site [30, 43]. 
The diffuse reflectance spectral data of  the reported Ni(II) complex are similar in nature and 
exhibited three bands in the regions 788-879 nm [3A2g (F)→3T2g (F)(ν1)], 635-659 nm [3A2g 
(F)→3T1g (F)( ν2)] and 331-405 nm [3A2g (F)→3T1g (P)( ν3)], which correspond to an overall 
octahedral symmetry. The electronic spectra of the Ni(II) complexes in  methanol are found to 
exhibit two bands in the regions 810-818 nm (ν1) and 524-532 nm (ν2),  which are nearly similar 
to those found in the solid state, thereby suggesting no gross electronic or geometric change of 
the complex species has taken place on dissolution in the said solvent. The ν3 band generally 
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appears due to 3A2g (F) → 3T1g (P) transition in the UV region was absent, this may be obscured 
by intense internal π→π* transition of the ligand or intense CT absorption bands [19b, 44]. 
The electronic spectra of complexes IV and V in methanol, have been found to exhibit two bands 
in the regions 206-208 nm and  251-254 nm,  are attributed to the  π-π* transition and one broad 
band appeared in the region 336-345 nm, may be assigned to the intra-ligand n-π* transition of 
the azomethine group [30b].  
1H NMR spectral data of the complexes IV and V when compared to those of the free ligand 
molecule, offered supportive information regarding the bonding characteristics of the primary 
ligand system in forming complexes with the concerned metal ions through the pyrazolyl ring 
nitrogen 2N(tertiary), azomethine nitrogen and thioether sulfur atom. It has been observed that 
peaks for the azomethine proton and C4-H (pyrazole ring) have been shifted to downfield regions 
in comparison to the free ligand (6.20 and 8.37 ppm for C4-H of pyrazole ring and azomethine 
proton, respectively); and singlets at δ 8.35-8.59 and 9.80-9.26 ppm, respectively, have been 
found. Whereas the C5-CH3 protons of pyrazole moiety suffered up field shifts at δ, 1.02-1.79 
ppm (δ=2.29 ppm for free ligand), and signal for S-CH3 protons have been found to shift to 
downfield (at δ= 2.53-3.15 ppm) in comparison to the free ligand (δ=2.33 for free ligand). The 
N-H(pyrazole) proton appeared in the downfield region δ=13.51-13.16 ppm (δ=12.99 for free 
ligand).  
 
3.2. Structural description 
The complex I crystallizes in monoclinic C2/c space group, whereas complexes II and III 
crystallize in monoclinic P21/n space group and complexes IV and V crystallize in triclinic P-1 
space group. The Molecular view with atom numbering scheme for I, II, III, IV and V are 
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shown in Figs 2, 3, 4, 5 and 6 respectively and some selected bond lengths and angles are given 
in Table-2. Ni(II) has a distorted octahedral coordination in the complex species I, II and III, 
having NiN4S2 chromospheres. A pair of MPzOATA ligands co-ordinates to the Ni(II) ion 
through the thioether sulfur, the tertiary nitrogen of the pyrazole ring and the azomethine 
nitrogen atoms. The two tridentate ligands bind Ni(II) centre one equatorially and the other trans-
axially.  
The crystallographic asymmetric unit in complex I consists of a [Ni(MPzOATA)2]2+ cation and 
two different counter anions, Cl- and PF6-, whereas, in complex II it comprises of  
[Ni(MPzOATA)2]2+ cation, two ClO4- anions and one molecule of acetonitrile as the solvent of 
crystallisation, H-bonded with the pyrazolyl secondary nitrogen. The crystallographic 
asymmetric unit in complex III is similar to that in I and II, except that III contains two BF4- as 
counter ions along with one molecule of water of crystallization. In I, two molecules of the 
(NNS) tridentate ligand, MPzOATA, coordinate to the Ni(II) ion to form four five-membered 
chelate rings, [Ni1-S1-C1-C2-N1, Ni1-S2-C13-C14-N4, Ni1-N1-C8-C9-N2A and Ni-N4-C20-
C21-N5]. The two azomethine nitrogen atoms are trans to each other, while the pyrazolyl ring 
nitrogen atoms and the sulphur atoms are in the cis positions. The coordination patterns of the in 
II and III are identical, except that we do not refer to the individual members of the pair of 
ligands as they are related by symmetry. The tridentate ligands in all the Ni(II) complexes are 
more or less planar, and the pair of coordinating ligands is nearly orthogonal to each other with 
the (acute) dihedral angles (between the pair of coordinating ligands) of 84.12º, 89.01º  and 
86.63º for I, II and III, respectively. The geometry about the Ni(II) ions in all the complexes 
compare well with those reported for other similar structures [45]. In I, the [Ni(MPzOATA)2]2+ 
cations are connected by the Cl- anions through N-H...Cl H-bonding interactions  and 1D infinite 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
chain has been generated running along the b axis. The pyrazolyl secondary nitrogen is acting as 
H-bond donor and involved in hydrogen bonding with the Cl atom (potential hydrogen-bond 
acceptor). The N–H, H...Cl and N...Cl distances are 0.95(18)-0.992(18), 2.12(2)-2.10(2) and 
3.044(3)-3.040(3) Å respectively, and the N–H...Cl angles are 163 and 159º (Fig. S1). 
 In II, the ClO4- anion and one acetonitrile solvent molecule are bonded to cation 
[Ni(MPzOATA)2]2+  by N(3A)-H(3AB)...O(21) and N(3B)-H(3BB)...N(1S) hydrogen bonding. 
One of the two ClO4- anions forms H-bonding with the cation through pyrazolyl nitrogen atom, 
whereas the other one is connected to the cation through the solvent molecule. The pyrazolyl 
secondary nitrogen is acting as hydrogen-bond donors with oxygen atom of perchlorate anion 
and nitrogen atom of solvent molecule as potential hydrogen-bond acceptors. The N-H, H...O 
and H…N(S), N...O and N…N(S) distances are  0.86, 1.98 and1.86, 2.829(4) and 2.719(5) Å 
respectively. The < (DHA) angles are170.5 and 172.9° (Fig. S2). 
In III, the fluoroborate and water molecule are bonded to the cation by N33-H33N…F62 and 
N13-H13…O401hydrogen bondings. The N-H, H...F and H…O, N...F and N…O distances are 
0.98, 1.80(3) and 1.82(3), 2.770(4) and 2.753(5) Å, respectively. The < (DHA) angle are 171(3) 
and 159(4)° respectively. In complex III intra-molecular hydrogen bonding was found between 
the pyrazole ring nitrogens as N13-H13…N12 and N33- H33N…N32 (Fig. S3). 
The unit cell of complex IV contains dinuclear neutral unit [Cd(MPzOATA)Cl2]2 in which two 
mononuclear Cd(MPzOATA)Cl units are bridged by two chloride ions. The complex species is a 
centrosymmetric dimer, the inversion centre is located at the midpoint between the two cadmium 
atoms.  Each metal centre is six coordinated by one molecule of MPzOATA ligand, bonded to 
the Cd(II) ion in a tridentate mode through the pyrazolyl (tertiary) ring nitrogen atom, [N1], 
azomethine nitrogen atom, [N2] and thioether sulfur atom [S1], forming two five-membered 
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chelate rings, [Cd-S(1)-C(11)-C(6)-N(2) and [Cd-N(2)-C(5)-C(4)-N(1)]; the other three 
coordination sites are occupied by two bridging and one non bridging chloride ions. Thus each 
cadmium (II) ion centre has a distorted octahedral coordination with CdN3SCl3 chromophore. 
The two non-bridging chlorine atom on each metal centre are trans to each other. The Cd···Cd 
distance is 3.689(3) Å, longer than the sum of van der Waals radii of cadmium (3.2 Å), [30b], 
indicating no effective intermetallic interaction. The two bite angles, N(2)–Cd–N(1) and N(2)–
Cd–S(1) of the five-membered chelate rings formed with the donor atoms N(2), N(1) and S(1) 
are 69.11(8) and 63.68(5) Å, respectively, indicating the largest distortion from the ideal 
octahedral geometry. Intra-molecular N-H...Cl contacts are observed between the secondary 
pyrazolyl nitrogen atoms (as H-atom donor) and the non-bridging chlorine atoms (as potential H-
bond acceptor) (Fig. S4). The N-H, H...Cl and N…Cl distances are found to be 0.88, 2.42 and 
3.286(2) Å respectively and the < (DHA) angle is 166.5°. 
 The asymmetric unit of complex V comprises of a Hg(II) ion, one unit of the neutral MPzOATA 
ligand and two coordinated chlorine atoms. The Hg(II) centre, having a HgN2SCl2 chromophore 
with a distorted square pyramidal geometry. The basal plane of the pyramid is formed by the 
pyrazolyl (tertiary) ring nitrogen atom, [N1], the azomethine nitrogen atom, [N2], one thioether 
sulfur atom [S2] of the coordinating ligand and one coordinated chlorine atom [Cl2]; the other 
coordinated chlorine atom [Cl1] occupies the apical position. The Hg–N bond distances vary in 
the range 2.413(4)–2.444(3) Å, while the Hg–S bond distance is 2.7505(10) Å. The basal 
mercury (II)–chlorine [Hg1–Cl2] distance is 2.4853(9) Å, while the axial mercury (II)–chlorine 
[Hg1–Cl1] distance is 2.4145(9) Å. In this complex, the geometric parameter τ is 0.21, indicating 
displacement from an ideal square-pyramidal geometry [19e, 46]. In the structure, each 
monomeric metal–organic unit is connected by N–H...Cl hydrogen bonding interactions, formed 
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between the secondary nitrogen atom of pyrazole and axial chlorine atom, leading to the 
formation of a dimer. These dimmers are further assembled by C-H...Cl hydrogen bonding 
interactions between azomethine carbon and another axial chlorine atom and form 1D 
supramolecular chains. The N–H, H...Cl and N...Cl distances and the N–H...A angle are found to 
be 0.88, 2.32 and 3.133(3) Å and 153.2°, respectively, and in C-H...Cl contacts, the C-H, H...Cl 
and C...Cl distances and the C-H...Cl angle are 0.95, 2.776 and 3.528(4) Å and 136.8°, 
respectively (Fig. S5) 
 
3.3. Fluorescence spectral study 
Fluorescence spectra of the complexes were recorded in methanol (2x10–5M) at room 
temperature. The complexes I, II and III are non-fluorescent, but complexes IV and V have 
shown characteristic fluorescence emissions. The fluorescence spectra of the complexes are 
shown in Fig.7. Intense emission bands for complex IV are observed at 503 nm when excited at 
254nm, but abrupt change of fluorescence emission intensity and wavelength at 432 nm was 
observed on changing the excitation wavelength at 336 nm. However, no appreciable emission 
was observed on changing the wavelength for complex V for which emission maxima was 
observed at 478 nm (λex = 251 nm). As Cd2+ and Hg2+ ions are difficult to be oxidized or reduced 
due to their stable d10 configuration, the emissions of their compounds cannot be attributed to 
either a metal-to-ligand charge transfer (MLCT) or a ligand to metal charge transfer (LMCT), 
and the primary ligand is also non-fluorescent. Therefore, the observed fluorescence intensity of 
the complex species may be attributed to increase in the conformational rigidity of the ligands 
due to chelate formation, which causes decrease in non-radiative decay of intra-ligand excited 
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states through vibrational motion [30b, 47-50]. The findings indicate that the complex species 
may be regarded as brilliant aspirants for photoactive material. 
 
3.4. Antimicrobial activity 
All the synthesized compounds under study showed active antimicrobial properties against six 
selected bacterial strains, but ligand did not exhibit any antimicrobial activity [16]. This may be 
due to ligand’s limited solubility in DMSO. The MIC values and inhibition zone diameters for 
these compounds are presented in Table 3 and 4. Complex I, II and III showed antimicrobial 
activity beyond the concentrations of 1225, 1000 and 750µg/mL, respectively. These three 
compounds were found to show antimicrobial property against a wide range of bacterial strains. 
Complex IV showed its MIC value in the range of 25-175 µg/mL. The bacterial strains 
Staphylococcus aureus and Proteus vulgaris OX19 were most sensitive against IV with MIC 
concentration of 25 and 35 µg/mL, respectively. With overall MIC values ranging from 5 to 55 
µg/mL, complex V exhibited an encouraging efficacy on Proteus vulgaris OX19 and 
Staphylococcus aureus with MIC concentrations of 5 and 20 µg/mL, respectively. All the five 
reported compounds showed broad spectrum antibacterial activity, being effective against both 
Gram positive and Gram negative microorganisms. The in vitro growth curves of two different 
bacterial species (Enterobacter aerogenes 10102 and Bacillus subtilis 6633) tested against the 
compounds as shown in Fig. 8 and Fig. 9, implied that the compounds tested have promising 
potential in inhibiting bacterial growth and hence can be effective as bacteriostatic agents. 
The result showed that membrane damage was inflicted by all the complexes, in general and   
was very significantly intensified (P< 0.05) by complex IV and V, in particular. With lapse of 
time the adverse effect increased (Fig. 10). Among the five complexes complex IV and V 
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showed encouraging efficiency in membrane damage against both gram positive (Bacillus 
subtilis 6633) and gram negative (Proteus vulgaris OX19) bacterial strain showing its wide 
window of antibacterial efficacy. This observation draws support from antimicrobial results 
involving some other complexes [51] Bacterial cell membrane acts as physiological barrier 
against the biocidal agents [41]. Hence such membrane damage assay reinforced our aforesaid 
antibacterial activity of the studied complexes by presenting their mechanism of antibacterial 
action through damage in membrane integrity.   
5. Conclusion 
Herein we intend to report the syntheses, spectral and structural characterization of some Ni(II), 
Cd(II) and Hg(II) complexes of a pyrazole containing Schiff base ligand, 5-methylpyrazole-3yl-
N-(2´-methylthiophenyl) methyleneimine, MPzOATA. Single crystal x-ray studies have 
authenticated all the three Ni(II) complexes as monomeric octahedral species. In Cd(II) complex, 
two metal centers are bridged by two chloride ions and each one have octahedral coordination. 
Whereas Hg(II) complex is monomeric square pyramidal one. Furthermore, the intense 
fluorescence property of the Cd(II) and Hg(II) complexes at room temperature, suggests that they 
have potential applications as photoactive materials. It has also been shown that the synthesized 
complexes have immense potential to act as broad-spectrum antimicrobial agents against both 
Gram positive and Gram negative bacteria through disruption of cell membrane integrity.   
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Appendix A. Supplementary data 
Crystallographic data for the structures reported here have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC nos. 1004238, 903321, 965608, 1048324, 1048330. Copies 
of this information may be obtained free of charge from the Director, CCDC, Data Centre, 12 
Union Road, Cambridge, CB2 1EZ, UK (fax: +44-1223-336-033; e-mail: 
deposit@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk). Figs. S1-S5 are available as 
supplementary material. 
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CAPTIONS TO THE FIGURES 
Fig. 1: Structural formulation of the ligand, MPzOATA. 
 
Fig. 2: Molecular view of complex I with atom numbering scheme.   
 
 
Fig.  3: Molecular view of complex II  with atom numbering scheme.   
 
Fig.  4: Molecular view of complex III with atom numbering scheme.   
 
Fig.  5: Molecular view of complex IV with atom numbering scheme.  
 
 Fig.  6: Molecular view of complex V with atom numbering scheme.   
 
Fig. 7: Fluorescence spectra of complex IV [ ______ (λemi = 432nm, λex= 336 nm); ____ (λemi = 
503 nm, λex= 254 nm)] and complex V [ ______ (λemi = 478 nm,  λex = 251 nm)]. 
 
Fig. 8: In vitro growth curve of Enterobacter aerogenes 10102 against the synthesized 
complexes: (a) complex I, (b) complex II, (c) complex III, (d) complex IV and (e) complex V  
 
Fig. 9: In vitro growth curve of Bacillus subtilis 6633 against the synthesized complexes: (a) 
complex I, (b) complex II, (c) complex III, (d) complex IV and (e) complex V 
 
Fig. 10: Membrane damage efficiency of the complexes against (a) Bacillus subtilis 6633 and (b) 
Proteus vulgaris OX19. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Fig. S1: View down the c-axis of the one-dimensional hydrogen-bonded chain formed in  
             complex I, running along the b-axis. Hydrogen atoms not involved in hydrogen  
             bonding, and PF6– anions are omitted. 
 
Fig. S2:  Hydrogen bonding pattern in complex II. 
 
Fig. S3:  Hydrogen bonding pattern in complex III. 
 
Fig. S4:  Packing diagram of complex IV with N-H...Cl hydrogen bonding interactions. 
 
Fig. S5:  Formation of 1D supramolecular chain structure in complex V by hydrogen bonding    
               interactions. 
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Table 1:  Crystal data and structure refinement parameters for   C24H26ClF6N6NiPS2 (I), C26H29Cl2N7NiO8S2 (II), C24H28B2F8N6NiOS2 (III), 
Cd(MPzOATA)Cl2]2 (IV) and [Hg(MPzOATA)Cl2] (V) 
                   
Crystal data                        Complex I                       Complex II                            Complex III                       Complex IV             Complex V                                             
Empirical formula         NiC24H26ClF6N6PS2              NiC26H29Cl2N7O8S2                 NiC24H28B2N6F8OS2           C24H26Cd2Cl4N6S2       C12H13HgN3Cl2S  
Formula weight                   701.75                                761.29                                     712.95                                 829.23                      502.80                                                          
Temperature (K)                  173                                        295                                           93                                     123(2)                      123(2) 
 Radiation [Å]                  MoKα 0.71075                  CuKα 1.54178                         MoKα 0.71075                  MoKα 0.71075            MoKα 0.71075                   
Crystal system                  Monoclinic                         Monoclinic                             Monoclinic                           Triclinic                   Triclinic                          
space group                        C2/c (#15)                           P21/n                                       P21/n                                     P-1                           P-1                                          
a (Å)       α (°)                19.981(18) 90                    8.4990(1) 90                            11.019(3) 90               8.6081(5) 93.274(4)   8.4533(4) 68.855(5)                                      
b (Å)       β (°)       12.964(10) 109.855(3)      19.1894(3) 93.146(1)               19.796(4) 103.658(6)       9.5951(4)  112.213(6)    9.4004(6)80.265(4)                        
c (Å)       γ (°)                 23.805(2) 90                  20.2945(3) 90                            14.370(4) 90              9.7627(6) 96.384(4)    11.0321(5)68.532(5)                                       
Volume (Å3)                     5799.7(9)                         3304.86(8)                               3045.9(13)                         737.56(7)                  760.21(7)                            
Z, Calc. density (Mg/m3)  8, 1.607                               4, 1.530                                 4, 1.555                              1, 1.867                      2, 2.197                                                                                                             
 µ(MoKα) [ /mm ]                 10.263                             4.016                                       0.854                                    1.972                        10.600 
F(000)                                   2864                               1568                                         1456                                      408                             472                                   
Crystal size (mm)         0.21 x 0.18 x 0.18        0.5725 x 0.2269 x 0.1056      0.12 x 0.12 x 0.12      0.7708 × 0.3037 × 0.1067     0.41 × 0.35 × 0.12                      
θ ranges (°)                   1.90 to 25.40                      4.4to 75.8                              0.0 to 25.4                            3.11 to 34.94             2.98 to 34.91                                     
Limiting indices         -24<= h <= 24                  -6<= h <= 10                         -9 <= h <= 13                         -13 <= h <= 13          -13 <= h <= 13                               
                                    -15 <= k <= 15               -23 <= k <= 24                       -23 <= k <= 22                        -14 <= k <= 15         -15 <= k <= 15                                
                                    -28 <= l <=26                 -25 <= l <=23                         -17 <= l <= 15                        -12 <= l <=15            -13 <= l <= 17                                                                    
Reflections collected         34924                              22823                                      19060                                   10310                         10475                                  
Unique reflections        5345[R(int)= 0.0520]      6745 [R(int) = 0.025]   5563[R(int)= 0.060]       5965[R(int) = 0.0391      6161[R(int)=0.0351]                                                                                                     
Refinement method      Full-matrix least               Full-matrix least            Full-matrix least                    Full-matrix least              Full-matrix least 
                                      -squares on F2                            -squares on F2                             -squares on F2                                    -squares on F2                             -squares on F2                                                                                               
Goodness-of-fit on F2         1.028                                1.026                               1.058                                        1.081                              1.025                                 
Final R indices [I>2σ (I)]     R1=0.0447                  R1 = 0.0484                       R1= 3934                                R1 = 0.0393                   R1= 0.0357                                                                                                                   
R indices (all data)               R1 = 0.0491                R1 = 0.0569                    R1 = 0.0525                             R1 = 0.0566                  R1 =0.0489                                           
                                           wR2=0.1214                wR2 = 0.1539                wR2 =0.1258                             wR2 = 0.0815              wR2 =0.0587                                     
Largest diff. peak, hole (e. Å-3) -0.53 and 1.04     -0.39and 0.53                 -0.43 and -0.51                        1.419 and -0.949            1.949 and -1.544                       
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 Table 2: Selected bond lengths (Å) and bond angles (º) for C24H26ClF6N6NiPS2 (I), C26H29Cl2N7NiO8S2 (II),   
 C24H28B2F8N6NiOS2 (III),  [Cd(MPzOATA)Cl2]2 (IV) and [Hg(MPzOATA)Cl2]  (V) 
 
  Complex I   Complex II  Complex III  Complex IV  Complex V  
Bond lengths 
(Å) 
 Bondlengths 
(Å) 
 Bond lengths 
(Å) 
 Bond lengths 
(Å) 
 Bond lengths 
(Å) 
 
Ni1–N1 2.044(2) Ni-N1A 2.042(3) Ni1 -N9 2.046(3) Cd-N(1) 2.367(2) Hg-N(1) 2.413(4) 
Ni1 –N2 2.056(3) Ni -N1B 2.041(2) Ni1 -N12 2.078(4) Cd-N(2) 2.383(2) Hg-N(2) 2.444(3) 
Ni1 –N4 2.035(3) Ni -N2A 2.071(3) Ni1 -N29 2.045(3) Cd-Cl(1) 2.496(8) Hg-S(1) 2.751(10) 
Ni1 –N5 2.067(2) Ni -N2B 2.068(3) Ni1 -N32 2.068(3) Cd-Cl(2) 2.526(7) Hg-Cl(1) 2.415(9) 
Ni1 –S1 2.418(10) Ni -S1A 2.436(9) Ni1 -S2 2.434(1) Cd-Cl(2)#1 2.724(7) Hg-Cl(2) 2.485(9) 
Ni1 -S2 2.427(8) Ni -S1B  2.430(9)  Ni1 -S22  2.415(1) Cd-S(1) 2.967(7) N(1)-C(4) 1.350(4) 
N1-C2 1.423(4) N1A-C7A 1.426(4)                                         N9-C4 1.423(6)                                                             N(2)-C(6) 1.418(3) C(4)-C(5) 1.455(5) 
C1-C2 1.396(5) C2A-C7A   1.395(5)                         C3-C4 1.399(6)                                                             C(6)-C(11) 1.401(3) C(5)-N(2) 1.271(5) 
S1-C1 1.781(3) S1A -C2A 1.778(3)              S2-C3  1.783(4)                                                             C(11)-S(1) 1.760(3) N(2)-C(6) 1.416(5) 
N1-C8 1.286(4) N1A-C8A  1.277(4)                       N9-C10   1.280(5)                                                        N(1)-C(4) 1.341(3) C(6)-C(11) 1.400(5) 
C8-C9 1.457(5) C8A-C9A  1.449(5)                       C10-C11                                              1.461(6)                                              C(4)-C(5) 1.453(4) C(11)-S(1) 1.770(3) 
N2-C9 1.339(4) N2A-C9A   1.338(4)                          C11-N12                                              1.340(5)                                                            C(5)-N(2) 1.278(3)   
N4-C14 1.413(4) N1B-C7B                   1.423(4) N29-C24 1.422(5)                                                     
C14-C13 1.388(4) C2B-C7B                           1.390(4) C24-C23                                   1.405(5)     
S2-C13 1.787(3) S1B-C2B                         1.778(4) S22-C23                                    1.782(4)     
N4-C20 1.302(4) N1B-C8B                              1.281(4)          N29-C30                                   1.292(5)                                      
C20-C21 1.428(5) C8B-C9B                                1.453(4) C30-C31                                    1.440(5)                                                           
C21-N5 1.333(4) N2B-C9B                                1.340(4) C31-N32                 1.358(5)     
          
Bond angles (°)  Bond angles 
(°) 
 Bond angles (°)  Bond angles (°)  Bond angles (°)  
N1-Ni1-N2 79.17(10) N1A-Ni-N1B 177.25(10) N9-Ni1-N12 78.92(12) S(1)-Cd-N(1) 109.78(6) N(1)-Hg-N(2) 67.59(11) 
N1-Ni1-N4 176.17(11) N1A-Ni-N2A 78.99(10) N9-Ni1-N29 176.93(11) N(1)-Cd-Cl(1) 156.60(7) S(1)-Hg-N(2) 69.77(8) 
N4-Ni1-N5 79.42(10) N1A-Ni-N2B 97.93(10) N9-Ni1-N32 97.55(12) N(2)-Cd-Cl(1) 102.14(6) S(1)-Hg-N(1) 123.41(7) 
N2-Ni1-N4 98.89(11) N1B-Ni-N2A 101.17(10) N12-Ni1-N29 100.65(12) N(1)-Cd-Cl(2) 95.84(6) Cl(1)-Hg-Cl(2) 115.11(3) 
N1-Ni1-N5 103.74(10) N1B-Ni-N2B 79.33(10) N12-Ni1-N32 92.87(12) N(2)-Cd-Cl(2 136.96(6) Cl(1)-Hg-S(1) 119.40(3) 
N2-Ni1-N5 88.20(11) N2A-Ni-N2B 92.89(10) N29-Ni1-N32 79.41(12) Cl(1)-Cd-Cl(2 104.41(3) Cl(1)-Hg-N(1) 108.24(8) 
S1-Ni1-S2 91.31(3) S1A-Ni-S1B 85.03(3) S2-Ni1-S22 84.93(4)  N(1)-Cd-Cl(2)#1 80.72(6) Cl(1)-Hg-N(2) 108.33(7) 
S1-Ni1-N1 82.77(8) S1A-Ni-N1A 82.75(7) S2-Ni1-N9 83.14 N(2)-Cd-Cl(2)#1 123.84(5) Cl(2)-Hg-S(1) 86.98(3) 
S1-Ni1-N2 160.83(7) S1A-Ni-N1B 97.30(7) S2-Ni1-N12 161.55(9)  Cl(1)-Cd-Cl(2)#1 87.30(2) Cl(2)-Hg-N(1) 99.51(8) 
S1-Ni1-N4 99.50(9) S1A-Ni-N2A 161.12(7) S2-Ni1-N29 97.52 Cl(2)-Cd-Cl(2)#1 90.80(2) Cl(2)-Hg-N(2) 136.51(7) 
S1-Ni1-N5 89.88(9) S1A-Ni-N2B 94.34(8) S2-Ni1-N32 93.61(10) N(2)-Cd-S(1) 63.68(5)   
S2-Ni1-N5 162.46(8) S1B-Ni-N2A 93.27(7) S22-Ni1-N12 93.95(9)  Cl(1)-Cd-S(1) 83.44(2)   
S2-Ni1-N1 93.77(6) S1B-Ni-N2B 162.23(8) S22-Ni1-N9 99.67 Cl(2)-Cd-S(1) 86.41(2)   
S2-Ni1-N4 83.12(7) S1B-Ni-N1A 99.60(7) S22-Ni1-N29 83.40 Cl(2)#1-Cd-S(1) 169.34(2)   
S2-Ni1-N2 96.23(7) S1B-Ni-N1B 83.14(7) S22-Ni1-N32 162.41(8)  N(1)-Cd-N(2) 69.11(8)   
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Table 3: MIC values (µg/mL)  of the synthesized complexes against the selected bacterial strains 
Organisms Complex 
I 
Complex 
II 
Complex 
III 
Complex 
IV 
Complex 
V 
Amoxicillin 
Escherichia coli K12 1575 1450 1550 175 20 7 
Salmonella enterica ser. typhi SRC 1550 1000 1550 45 55 31 
Proteus vulgaris OX19 1300 1450 975 35 5 129 
Bacillus subtilis 6633 1225 1050 750 40 25 28 
Staphylococcus aureus 1275 1625 1225 25 20 85 
Enterobacter aerogenes 10102 1300 1425 1400 175 35 280 
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Table 4: Growth inhibition zone diameter of MIC (mm) of synthesized complexes against the 
selected bacterial strains 
Organism Complex 
I 
Complex 
II 
Complex 
III  
Complex 
IV 
Complex 
V 
Amoxicillin 
Escherichia coli K12 4.3±0.2 3.2±0.3 3.7±0.5 4.2 ±0.4 2.5±0.2 12.3±0.4 
Salmonella enteric ser. typhi SRC 1.9±0.1 6.8±0.2 2.1±0.3 2.5±0.1 3.1±0.2 9.4±0.2 
Proteus vulgaris OX19 2.1±0.1 2.2±0.1 2.5±0.2 3.8±0.2 6.9±0.5 7.6±0.5 
Bacillus subtilis 6633 6.8±0.3 3.8±0.3 6.5±0.4 5.5±0.3 7.6±0.5 8.5±0.1 
Staphyloccus aureus 2.1±0.1 2.3±0.3 1.8±0.2 3.5±0.1 8.5±0.5 7.2±0.6 
Enterobacter aerogenes 10102 6.2±0.4 2.5±0.4 4.1±0.2 5.5±0.3 4.1±0.2 8.4±0.5 
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Highlights (for review) 
Syntheses, physico-chemical and spectroscopic characterizations of five new Ni(II), Cd(II) & 
Hg(II) complexes of a pyrazole containing Schiff-base ligand have been reported. 
X-ray crystallographic studies on all the reported complex species have authenticated the 
structures of the complexes as envisaged from spectroscopy. 
Photoluminescence property of the complexes has been studies; Cd(II) and Hg(II) complexes 
have been shown to be fluorescence active. 
Antimicrobial activities of the complexes against some Gram positive and Gram negative 
bacteria have been reported, and the complexes have been found to be the potential antimicrobial 
agents in broad spectrum against the both. 
 
 
    
 
